Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Mannose efflux from the cells: a potential source of mannose in blood.

Sharma V, Freeze HH.

J Biol Chem. 2011 Mar 25;286(12):10193-200. doi: 10.1074/jbc.M110.194241. Epub 2011 Jan 27.

2.

Human fibroblasts prefer mannose over glucose as a source of mannose for N-glycosylation. Evidence for the functional importance of transported mannose.

Panneerselvam K, Etchison JR, Freeze HH.

J Biol Chem. 1997 Sep 12;272(37):23123-9. Erratum in: J Biol Chem 1997 Dec 26;272(52):33444.

3.

Chinese hamster ovary cells with reduced hexokinase activity maintain normal GDP-mannose levels.

O'Rear JL, Scocca JR, Walker BK, Kaiden A, Krag SS.

J Cell Biochem. 1999 Jan 1;72(1):56-66.

PMID:
10025667
4.
5.

Inhibitors of the biosynthesis and processing of N-linked oligosaccharides.

Elbein AD.

CRC Crit Rev Biochem. 1984;16(1):21-49. Review.

PMID:
6232113
6.
8.

Redefining the facilitated transport of mannose in human cells: absence of a glucose-insensitive, high-affinity facilitated mannose transport system.

Rodríguez P, Rivas CI, Godoy A, Villanueva M, Fischbarg J, Vera JC, Reyes AM.

Biochemistry. 2005 Jan 11;44(1):313-20.

PMID:
15628873
9.

Core fucosylation of high-mannose-type oligosaccharides in GlcNAc transferase I-deficient (Lec1) CHO cells.

Lin AI, Philipsberg GA, Haltiwanger RS.

Glycobiology. 1994 Dec;4(6):895-901.

PMID:
7734851
11.

Direct utilization of mannose for mammalian glycoprotein biosynthesis.

Alton G, Hasilik M, Niehues R, Panneerselvam K, Etchison JR, Fana F, Freeze HH.

Glycobiology. 1998 Mar;8(3):285-95.

PMID:
9451038
13.

Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.

Gozalpour E, Greupink R, Wortelboer HM, Bilos A, Schreurs M, Russel FG, Koenderink JB.

Mol Pharm. 2014 Jun 2;11(6):1844-55. doi: 10.1021/mp400699p. Epub 2014 May 6.

PMID:
24754247
14.

High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin.

Galustian C, Park CG, Chai W, Kiso M, Bruening SA, Kang YS, Steinman RM, Feizi T.

Int Immunol. 2004 Jun;16(6):853-66. Epub 2004 May 10.

PMID:
15136555
17.

Engineering cell metabolism for high-density cell culture via manipulation of sugar transport.

Wlaschin KF, Hu WS.

J Biotechnol. 2007 Aug 31;131(2):168-76. Epub 2007 Jun 23.

PMID:
17662499
19.

Release of oligomannoside-type glycans as a marker of the degradation of newly synthesized glycoproteins.

Villers C, Cacan R, Mir AM, Labiau O, Verbert A.

Biochem J. 1994 Feb 15;298 ( Pt 1):135-42.

Supplemental Content

Support Center